These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [An influence of mexidol on the restoration of neurological deficit, increase of social adaptation and removal of neglect and push syndromes in stroke patients]. Koval'chuk VV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):52-7. PubMed ID: 22792750 [TBL] [Abstract][Full Text] [Related]
29. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L; Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670 [TBL] [Abstract][Full Text] [Related]
30. [Ideology of the modern system of stroke prevention]. Shirokov EA Klin Med (Mosk); 2014; 92(3):5-10. PubMed ID: 25269188 [TBL] [Abstract][Full Text] [Related]
31. Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives. Kaundal RK; Deshpande TA; Gulati A; Sharma SS Drug Discov Today; 2012 Jul; 17(13-14):793-804. PubMed ID: 22406696 [TBL] [Abstract][Full Text] [Related]
32. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Hill MD; Rowley HA; Adler F; Eliasziw M; Furlan A; Higashida RT; Wechsler LR; Roberts HC; Dillon WP; Fischbein NJ; Firszt CM; Schulz GA; Buchan AM; Stroke; 2003 Aug; 34(8):1925-31. PubMed ID: 12843342 [TBL] [Abstract][Full Text] [Related]
33. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B; Martínez-Sánchez P; Díez-Tejedor E Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [TBL] [Abstract][Full Text] [Related]
34. [Etiology and pathogenesis, diagnosis and management of stroke in women]. Koval'chuk VV; Skoromets AA Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():10-7. PubMed ID: 18193763 [TBL] [Abstract][Full Text] [Related]
35. Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Lioutas VA; Alfaro-Martinez F; Bedoya F; Chung CC; Pimentel DA; Novak V Transl Stroke Res; 2015 Aug; 6(4):264-75. PubMed ID: 26040423 [TBL] [Abstract][Full Text] [Related]
36. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study. Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke]. Chefranova ZhIu; Makotrova TA; Udachin VA; Koledintseva EV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):49-52. PubMed ID: 22810741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]